Cronos Group Inc vs Enphase Energy Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.20B), while Enphase Energy Inc trades at $33.24 (market cap $4.43B). The key difference: Enphase Energy Inc is far larger — about 3.7× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Enphase Energy Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Enphase Energy Inc for 72 Days on average.
| CRON | ENPH | |
|---|---|---|
Market Cap | $1.20B | $4.43B |
Volume | 450,387 | 3,388,482 |
Sector | Health | Energy |
52-Week High | $3.55 | $72.33 |
52-Week Low | $2.30 | $26.12 |
Typical Hold Time | 22 Days | 72 Days |
Enterprise Value | $401.73M | $4.07B |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 1.98% on the day, amid a bearish technical signal. The company reported mixed quarterly earnings but achieved record revenue and gross profit in Q2 2026, with net income turning positive. Recent investor day highlighted international expansion and cash flow focus. Valuation ratios show a P/E of 17.11 and P/S of 6.91, with strong net income margin of 39.08% projected for 2026.
Outlook is cautiously optimistic, driven by revenue growth and profitability improvements, but risks include cash flow volatility and competitive pressures. Analyst consensus is mixed with 60% hold rating. The stock's near-term performance hinges on execution of expansion plans and sustained earnings momentum.
Enphase Energy (ENPH) trades at $32.91, down 2.95% on the day, amid a bearish technical signal and mixed earnings history. The stock shows weakening revenue and net income from 2023 peaks, with 2025 revenue at $1.47B and net income of $172.13M. Recent news highlights volatility in solar stocks due to high borrowing costs, though Enphase advances with IQ Meter Collar approvals and solid-state transformer development for AI data centers.
Outlook is cautious; while analyst consensus targets $42.90 (30% upside), recent earnings misses and bearish technicals suggest near-term pressure. Risks include solar industry headwinds and execution challenges, but long-term growth potential exists in energy technology expansion. Investors should weigh valuation metrics like P/E of 33.17 against competitive and macroeconomic risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →